Skip to content
10-Q

Quarterly Report

NEUROPACE, INC. NPCE

0001528287-25-000013

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 32.8M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $59.79M
Long Term Debt Q1 2025 · Dec 31, 2024 $59.53M
Short Term Investments Q1 2025 · Mar 31, 2025 $39.24M
Short Term Investments Q1 2025 · Dec 31, 2024 $39.33M
Current Liabilities Q1 2025 · Mar 31, 2025 $14.71M
Current Liabilities Q1 2025 · Dec 31, 2024 $15.16M
Total Liabilities Q1 2025 · Mar 31, 2025 $85.94M
Total Liabilities Q1 2025 · Dec 31, 2024 $86.63M
Current Assets Q1 2025 · Mar 31, 2025 $97.48M
Current Assets Q1 2025 · Dec 31, 2024 $81.34M
Total Assets Q1 2025 · Mar 31, 2025 $110.21M
Total Assets Q1 2025 · Dec 31, 2024 $94.65M
Sga Expense Q1 2025 · Mar 31, 2025 $15.05M
Sga Expense Q1 2025 · Mar 31, 2024 $15.1M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $13.43M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $13M
Shares Diluted Q1 2025 · Mar 31, 2024 28.29M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $0
Capex Q1 2025 · Mar 31, 2024 $104K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$7.53M
Stockholders Equity Q1 2025 · Mar 31, 2024 $14.34M
Stockholders Equity Q1 2025 · Dec 31, 2023 $20.65M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.32
Eps Basic Q1 2025 · Mar 31, 2024 −$0.32
Rd Expense Q1 2025 · Mar 31, 2024 $5.78M
Net Income Q1 2025 · Mar 31, 2024 −$8.93M
Operating Income Q1 2025 · Mar 31, 2024 −$7.55M
Gross Profit Q1 2025 · Mar 31, 2024 $13.34M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $4.78M
Revenue Q1 2025 · Mar 31, 2024 $18.12M